EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Revisiting the causal impact of lipid traits on metabolic dysfunction‐associated fatty liver disease: Insights from a multidimensional plasma lipid profile

Fang Xie, Wenkai Zheng, Jing Chen, Chuanxia Yao, Cong Li, Li Tang, Ping Li, Shanzhong Tan iD

Journal of Diabetes Investigation · 2025-05 · 16 (5) · 917-928

DOI: 10.1111/jdi.14413 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Investigation, online erschienen am 07.03.2025. Verfasst von Fang Xie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated TCM and Western Medicine, Nanjing Hospital Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, …. Hauptthemen laut MEDLINE: Lipids, Biomarkers, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Leading Talent Project of Jiangsu Province Traditional Chinese Medicine, Science and Technology Innovation Research Program of Jinling Hospital, Nanjing Health Science and Technology Development Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Recent advancements in plasma lipidomes genome‐wide association studies data have enhanced our understanding of lipid categories, significantly improving risk assessments for metabolic dysfunction‐associated fatty liver disease (MAFLD) beyond traditional lipid biomarkers. Materials and Methods This study utilized Mendelian randomization (MR) to assess the causal relationships between 179 lipid species across 13 subclasses and MAFLD, primarily using the Wald ratio and IVW methods. Corrections were made using false discovery rate (FDR), supplemented by Bayesian colocalization analysis.

Results

Elevated levels of genetically predicted phosphatidylcholine (16:0_16:1) [OR Wald ratio = 2.638, 95% CI 1.557–4.469, P = 3.11 × 10 −4 ], phosphatidylcholine (16:1_18:0) (OR Wald ratio = 2.644, 95% CI 1.559–4.486, P = 3.11 × 10 −4 ), triacylglycerol (46:2) (OR Wald ratio = 2.515, 95% CI 1.524–4.153, P = 3.11 × 10 −4 ), and triacylglycerol (48:2) (OR IVW = 1.863, 95% CI 1.300–2.669, P = 6.95 × 10 −4 ) were significantly associated with increased MAFLD risk, with rs1260326 within the GCKR gene playing a crucial role. Colocalization analysis indicated that in significant evidences, the posterior probability for hypothesis 4 was over 80%, identifying rs780093 as a shared causal variant. Additionally, 16 suggestive evidences were identified.

Conclusion

The study confirmed the significant role of specific lipid molecules in influencing MAFLD risk, providing new scientific bases and potential therapeutic targets for future treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipidsBiomarkersNon-alcoholic Fatty Liver DiseaseHumansMendelian Randomization AnalysisGenome-Wide Association StudyPolymorphism, Single NucleotideLipid Metabolism

Stichwörter der Autor:innen

Causal associationMendelian randomizationMetabolic dysfunction‐associated fatty liver disease

Substanzen

LipidsBiomarkers

Autor:innen und Institutionen

  • Department of Integrated TCM and Western Medicine, Nanjing Hospital Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China.
  • Department of Liver Disease, Jinling Hospital Affiliated to Medical College of Nanjing University, Nanjing, Jiangsu Province, China.
  • Department of Gastroenterology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China.

ORCID-Profile: Shanzhong Tan

Förderung

  • Leading Talent Project of Jiangsu Province Traditional Chinese Medicine
  • Science and Technology Innovation Research Program of Jinling Hospital
  • Nanjing Health Science and Technology Development Project

Zitieren

APA

Xie, F., Zheng, W., Chen, J., Yao, C., Li, C., Tang, L., Li, P., & Tan, S. (2025). Revisiting the causal impact of lipid traits on metabolic dysfunction‐associated fatty liver disease: Insights from a multidimensional plasma lipid profile. Journal of Diabetes Investigation, 16(5), 917-928. https://doi.org/10.1111/jdi.14413

Vancouver

Xie F, Zheng W, Chen J, Yao C, Li C, Tang L, et al. Revisiting the causal impact of lipid traits on metabolic dysfunction‐associated fatty liver disease: Insights from a multidimensional plasma lipid profile. Journal of Diabetes Investigation. 2025;16(5):917-928. doi:10.1111/jdi.14413

BibTeX
@article{Xie2025,
  author = {Xie, Fang and Zheng, Wenkai and Chen, Jing and Yao, Chuanxia and Li, Cong and Tang, Li and Li, Ping and Tan, Shanzhong},
  title = {Revisiting the causal impact of lipid traits on metabolic dysfunction‐associated fatty liver disease: Insights from a multidimensional plasma lipid profile},
  journal = {Journal of Diabetes Investigation},
  year = {2025},
  volume = {16},
  number = {5},
  pages = {917--928},
  doi = {10.1111/jdi.14413}
}
Kostenlos starten →